GW Pharmaceuticals plc gibt Finanzergebnisse und operativen Fortschritt für das am 31. Dezember 2018 endende Quartal bekannt
26.02.2019 GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018 LONDON and CARLSBAD, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the